Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 31 active records with this name as holder; 30 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
60 acceptance records as first applicant, grouped into 31 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
二甲双胍格列吡嗪片 · No verified English name 1 records · Latest accepted 2026/05/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650123 | Supplement | 2026/05/21 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
甲磺酸奥达替尼胶囊 · No verified English name 2 records · Latest accepted 2026/02/04
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600021 | New drug | 2026/02/04 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHS2600020 | New drug | 2026/02/04 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2025/11/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503960 | Generic | 2025/11/14 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Glycerol Fructose And Sodium Chloride Injection 1 records · Latest accepted 2025/10/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550347 | Supplement | 2025/10/28 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
复方聚乙二醇电解质散(3350) · No verified English name 2 records · Latest accepted 2025/09/04
Supplement · 1Generic · 1
Atomoxetine Hydrochloride Capsules 6 records · Latest accepted 2025/08/15
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501631 | Supplement | 2025/08/15 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501630 | Supplement | 2025/08/15 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501629 | Supplement | 2025/08/15 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350592 | Supplement | 2023/07/25 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2250537 | Supplement | 2022/08/29 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2250536 | Supplement | 2022/08/29 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
螺内酯片 · No verified English name 3 records · Latest accepted 2025/03/27
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550160 | Supplement | 2025/03/27 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2500431 | Supplement | 2025/03/04 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150924 | Supplement | 2021/10/19 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Brivaracetam Oral Solution 1 records · Latest accepted 2025/02/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500876 | Generic | 2025/02/28 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CDE ↗ |
Sodium Bicarbonate Injection 3 records · Latest accepted 2024/10/12
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450515 | Supplement | 2024/10/12 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201842 | Supplement | 2022/10/10 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2100106 | Supplement | 2021/01/19 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
FHND6091胶囊 · No verified English name 8 records · Latest accepted 2024/09/26
New drug · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401007 | New drug | 2024/09/26 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2401006 | New drug | 2024/09/26 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400119 | New drug | 2024/01/28 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400118 | New drug | 2024/01/28 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301447 | New drug | 2023/12/26 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301446 | New drug | 2023/12/26 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2100132 | New drug | 2021/02/23 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2100131 | New drug | 2021/02/23 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
复方电解质醋酸钠葡萄糖注射液 · No verified English name 2 records · Latest accepted 2024/07/27
Generic · 2
Multiple Electrolyte Additive For Injection 1 records · Latest accepted 2024/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402252 | Generic | 2024/07/18 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
孟鲁司特钠颗粒 · No verified English name 1 records · Latest accepted 2024/02/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400207 | Supplement | 2024/02/05 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
FHND1002颗粒 · No verified English name 6 records · Latest accepted 2024/01/11
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400056 | New drug | 2024/01/11 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400055 | New drug | 2024/01/11 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301108 | New drug | 2023/10/13 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301107 | New drug | 2023/10/13 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301106 | New drug | 2023/10/13 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301105 | New drug | 2023/10/13 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Tedizolid Phosphate For Injection 1 records · Latest accepted 2023/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303356 | Generic | 2023/12/06 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Polaprezinc Granules 1 records · Latest accepted 2023/07/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301999 | Generic | 2023/07/26 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Urapidil Hydrochloride Injection 1 records · Latest accepted 2023/03/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300676 | Generic | 2023/03/03 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
泊沙康唑注射液 · No verified English name 1 records · Latest accepted 2023/02/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300570 | Generic | 2023/02/18 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Esmolol Hydrochloride Injection 1 records · Latest accepted 2022/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202174 | Generic | 2022/12/31 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Esomeprazole Sodium for Injection 1 records · Latest accepted 2022/07/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201277 | Supplement | 2022/07/27 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Calcium Gluconate in Sodium Chloride Injection 1 records · Latest accepted 2022/05/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200815 | Generic | 2022/05/31 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Fudosteine oral solution 1 records · Latest accepted 2022/05/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200723 | Generic | 2022/05/11 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Calcium Gluconate Injection 1 records · Latest accepted 2022/05/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250265 | Supplement | 2022/05/10 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanized | CDE ↗ |
Atomoxetine Hydrochloride Oral Solution 1 records · Latest accepted 2022/05/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200704 | Generic | 2022/05/06 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CDE ↗ |
FHND5071片 · No verified English name 2 records · Latest accepted 2022/01/14
New drug · 2
Dexmedetomidine Hydrochloride Injection 1 records · Latest accepted 2021/07/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101468 | Generic | 2021/07/24 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
FHND9041胶囊 · No verified English name 2 records · Latest accepted 2021/06/30
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2101063 | Supplement | 2021/06/30 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CXHB2101062 | Supplement | 2021/06/30 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
消旋卡多曲颗粒 · No verified English name 2 records · Latest accepted 2021/05/25
Supplement · 2
聚普瑞锌颗粒? · No verified English name 1 records · Latest accepted 2021/05/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101166 | Generic | 2021/05/19 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
复方醋酸钠林格注射液 · No verified English name 2 records · Latest accepted 2021/05/07
Supplement · 2
Alanyl Glutamine Injection 2 records · Latest accepted 2021/04/10
Supplement · 2
Changes in the last 90 days
1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Supplement delivery: 1 application
- 2026/10/16Supplement delivery
Glycerol Fructose And Sodium Chloride Injection
CYHB2550347
Fact date: 2026/10/16 · Publication date: 2026/10/21 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 5 ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 二甲双胍格列吡嗪片 · No verified English name | CYHB2650123 | Supplement | 2026/05/21 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
| 甲磺酸奥达替尼胶囊 · No verified English name | CXHS2600021 | New drug | 2026/02/04 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 甲磺酸奥达替尼胶囊 · No verified English name | CXHS2600020 | New drug | 2026/02/04 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2503960 | Generic | 2025/11/14 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
31 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20263932 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20263933 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 螺内酯片 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H32020077 | 2026/02/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 螺内酯片 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20269035 | 2026/02/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Multiple Electrolyte Additive For Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20256350 | 2025/12/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方聚乙二醇(3350)电解质散 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20256025 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20258141 | 2025/07/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tedizolid Phosphate For Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20254804 | 2025/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20249168 | 2024/10/22 | Not stated by source | CDE ↗ |
| Urapidil Hydrochloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20249052 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esmolol Hydrochloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20244395 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atomoxetine Hydrochloride Capsules | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20133346 | 2024/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 复方醋酸钠林格注射液 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20173334 | 2023/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 复方醋酸钠林格注射液 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20173335 | 2023/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Calcium Gluconate in Sodium Chloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20234337 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atomoxetine Hydrochloride Capsules | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20237105 | 2023/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Atomoxetine Hydrochloride Capsules | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20237104 | 2023/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Calcium Gluconate Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanized | 国药准字H32020080 | 2023/07/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20233337 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alanyl Glutamine Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20066545 | 2022/09/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20227113 | 2022/09/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 消旋卡多曲颗粒 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20051055 | 2022/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 消旋卡多曲颗粒 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20051055 | 2022/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 螺内酯片 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20205025 | 2021/11/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Edaravone Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20213532 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20193317 | 2021/01/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20183528 | 2020/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20183529 | 2020/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20183412 | 2020/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 孟鲁司特钠颗粒 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20203044 | 2020/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glycerol Fructose And Sodium Chloride Injection | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 国药准字H20055041 | 2026/10/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
30 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 甲磺酸奥达替尼 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20250000997 | I | 2026/01/23 | CDE ↗ |
| 右莰醇 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20250001025 | I | 2025/09/28 | CDE ↗ |
| 布瑞哌唑 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20250000085 | A | 2026/06/01 | CDE ↗ |
| 孟鲁司特钠 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20240000834 | A | 2026/02/24 | CDE ↗ |
| 替硝唑 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20240000183 | A | 2025/09/30 | CDE ↗ |
| 磷酸特地唑胺 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20230001126 | A | 2025/07/13 | CDE ↗ |
| 泊沙康唑 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20230000020 | A | 2024/10/31 | CDE ↗ |
| 盐酸艾司洛尔 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20220001114 | A | 2025/03/01 | CDE ↗ |
| 盐酸乌拉地尔 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20220000948 | A | 2024/12/10 | CDE ↗ |
| 盐酸托莫西汀 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20210000523 | A | 2026/06/16 | CDE ↗ |
| 葡萄糖酸钙 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20210000167 | A | 2024/03/16 | CDE ↗ |
| 碳酸氢钠 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20210000020 | A | 2023/07/15 | CDE ↗ |
| 盐酸右美托咪定 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20200001381 | A | 2026/07/24 | CDE ↗ |
| 聚普瑞锌 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190021557 | A | 2026/08/25 | CDE ↗ |
| 硫酸锌 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20200000326 | A | 2026/08/18 | CDE ↗ |
| 消旋卡多曲 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004872 | A | 2025/07/18 | CDE ↗ |
| 右旋糖酐70 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004256 | A | — | CDE ↗ |
| 右旋糖酐40 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004240 | A | — | CDE ↗ |
| 尿囊素 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004234 | A | 2025/05/27 | CDE ↗ |
| 右旋糖酐20 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004227 | A | — | CDE ↗ |
| 果糖 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190004218 | A | 2025/07/24 | CDE ↗ |
| 福多司坦 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20190000727 | A | 2025/01/24 | CDE ↗ |
| 磷酸二氢钾 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170001637 | I | — | CDE ↗ |
| 磷酸氢二钾三水合物 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170001636 | I | — | CDE ↗ |
| 奥拉西坦 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170001105 | I | — | CDE ↗ |
| 艾司奥美拉唑钠 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170000867 | A | 2024/10/24 | CDE ↗ |
| 米力农 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170000810 | I | — | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170000806 | A | 2025/03/20 | CDE ↗ |
| 利奈唑胺 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170000412 | A | 2026/08/07 | CDE ↗ |
| 依达拉奉 · No verified English name | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Y20170000078 | A | 2024/11/28 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.